Next Article in Journal
Improved “General Unknown” Drug Screening Using GCxGCqMS
Previous Article in Journal
Using Multiple Approaches in Docking Pose Evaluation – Application to the GABAA Receptor
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 77
Issue 6
10.3797/scipharm.oephg.21.SL-15
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Nucleofection® & other Technologies Enabling Advances in Pharmaceutical Research

by
K. J. MOBBS
* and
N. FAUST
Lonza-Cologne, Nattermannelle 1, 50829 Köln, Germany
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(6), 182; https://doi.org/10.3797/scipharm.oephg.21.SL-15
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Versions Notes

Abstract

The maintenance of physiological relevance in cell models while introducing nucleic acids and other molecules is key to effective life science research and the efficient development of novel therapies. The increasing drive toward use of primary cells is triggered by the limitations of ‘easy-to-use’ cell lines, such as their predictive power regarding whole-organism physiology. The use of physiologically relevant and validated cell models together with technologies enabling the fine dissection of signal transduction and metabolic pathways is pivotal in increasing the efficiency of pharmaceutical research and development.

Share and Cite

MDPI and ACS Style

MOBBS, K.J.; FAUST, N. Nucleofection® & other Technologies Enabling Advances in Pharmaceutical Research. Sci. Pharm. 2009, 77, 182. https://doi.org/10.3797/scipharm.oephg.21.SL-15

AMA Style

MOBBS KJ, FAUST N. Nucleofection® & other Technologies Enabling Advances in Pharmaceutical Research. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):182. https://doi.org/10.3797/scipharm.oephg.21.SL-15

Chicago/Turabian Style

MOBBS, K. J., and N. FAUST. 2009. "Nucleofection® & other Technologies Enabling Advances in Pharmaceutical Research" Scientia Pharmaceutica 77, Short Lectures (SL): 182. https://doi.org/10.3797/scipharm.oephg.21.SL-15

APA Style

MOBBS, K. J., & FAUST, N. (2009). Nucleofection® & other Technologies Enabling Advances in Pharmaceutical Research. Scientia Pharmaceutica, 77(Short Lectures (SL)), 182. https://doi.org/10.3797/scipharm.oephg.21.SL-15

Article Metrics

Back to TopTop